Bed Sore Management
For established pressure ulcers, use hydrocolloid or foam dressings for wound care, provide protein or amino acid supplementation, and consider electrical stimulation as adjunctive therapy to accelerate healing. 1
Core Treatment Approach
The American College of Physicians provides evidence-based recommendations that should guide your management strategy:
1. Wound Dressing Selection
Choose hydrocolloid or foam dressings over traditional gauze. 1 These advanced dressings are superior to gauze for reducing wound size and achieve similar complete healing rates when compared to each other. The evidence shows hydrocolloid dressings specifically outperform gauze, while being equivalent to foam dressings (hydrocellular or polyurethane) for complete wound healing. Avoid dextranomer paste, which has been shown to be inferior to other dressing options. 1
2. Nutritional Support
Provide protein or amino acid supplementation to all patients with pressure ulcers. 1 This intervention reduces wound size, though the optimal dose or specific form of protein remains unclear. This recommendation is particularly important for patients with nutritional deficiencies, which are common in those with pressure ulcers. Note that vitamin C supplementation has not shown benefit compared to placebo. 1
3. Adjunctive Electrical Stimulation
Consider electrical stimulation as add-on therapy for stage 2-4 ulcers. 1 This has moderate-quality evidence supporting its ability to accelerate wound healing rates when added to standard treatment. However, be cautious in frail elderly patients who are more susceptible to adverse events, particularly skin irritation. 1
Pressure Relief Strategy
Use air-fluidized beds when available, as they are superior to standard hospital beds for reducing ulcer size. 1 However, avoid expensive alternating-air beds and low-air-loss mattresses—they don't show substantial benefit over other surfaces for reducing wound size and add unnecessary healthcare costs. 1 Standard repositioning and pressure redistribution remain fundamental.
Wound Assessment and Monitoring
Document each ulcer systematically: 2
- Size and location (measure objectively at each assessment)
- Stage (I through IV)
- Tissue characteristics (eschar, granulation tissue, necrotic debris)
- Exudate (amount, color, consistency)
- Signs of infection (odor, cellulitis, purulent drainage)
- Wound edges (undermining, sinus tracts)
Debridement Considerations
Perform urgent sharp debridement if advancing cellulitis or sepsis is present. 2 For non-urgent situations, mechanical, enzymatic, or autolytic debridement methods are appropriate when necrotic tissue is present. 1 The evidence for specific debriding enzymes compared to other topical therapies remains insufficient. 1
Infection Management
- Cleanse wounds with normal saline as the preferred agent 2
- Consider topical antibiotics only if no healing improvement after 14 days of standard care 2
- Use systemic antibiotics for: advancing cellulitis, osteomyelitis, or systemic infection 2
- Bacterial load can typically be managed with appropriate cleansing alone
Pain Management
Address pain systematically as part of comprehensive care, though specific evidence-based protocols for pressure ulcer pain are limited in the guidelines. Pain control contributes significantly to quality of life and should be individualized based on severity and patient factors.
What NOT to Do
Avoid these interventions lacking evidence or showing no benefit: 1
- Negative-pressure wound therapy (no benefit over controls)
- Electromagnetic therapy
- Therapeutic ultrasound
- Laser therapy
- Radiant heat dressings (accelerate healing but don't improve complete wound healing)
- Light therapy (reduces ulcer size but equivalent to sham for complete healing)
Surgical Considerations
For advanced-stage (stage IV) pressure ulcers, surgery may be considered, though evidence is insufficient to determine superiority of one technique over another. 1 Be aware that dehiscence is more common when bone is removed and in patients with ischial ulcers. 1 Rotation flaps have lower complication rates (12%) compared to tensor fascia lata flaps (49%). 1
Common Pitfalls to Avoid
- Don't focus solely on the wound—address underlying pathologies (diabetes, peripheral vascular disease), functional status, and nutritional deficiencies 3
- Don't use expensive support surfaces without evidence—alternating-air and low-air-loss systems add costs without proven benefit 1
- Don't delay debridement when cellulitis or sepsis is advancing 2
- Don't overlook frail elderly patients when using electrical stimulation—they have higher adverse event rates 1
Monitoring and Goals
For acute ulcers, the goal is complete healing through optimized blood flow, management of underlying illnesses, and adequate nutrition. 3 When ulcers become chronic and healing is unlikely, shift goals to symptom control (odor, pain, infection prevention) and maintaining quality of life. 3 Regular reassessment is essential, as nearly all stage IV ulcers can be avoided with comprehensive early treatment. 4